Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Developing treatments for fatty liver disease has proved challenging, and there are currently no approved medications.
Optimal treatment for fatty liver disease may involve combining drugs with different mechanisms of action.
A recent study also found that having a higher body mass index was associated with a higher risk of fatty liver disease.
The prevalence of abnormal liver tests in people hospitalized with COVID-19 is higher than previously found.
Using a two-part testing plan could help identify those with advanced liver fibrosis among people with type 2 diabetes.
Age, underlying medical conditions, race/ethnicity and economic status all play a role in determining the risk for severe illness.
Researchers reported significant changes in liver, cardiovascular and diabetes markers.
As with HIV-negative individuals, non-alcoholic fatty liver disease is tied to diabetes and irregular blood lipids in those with HIV.
People with cancer, heart disease and diabetes are at increased risk for serious illness from COVID-19.
Non-alcoholic fatty liver disease is more common among those with the virus compared with the general population.
This finding, which is in keeping with initial studies out of China and Italy, is preliminary as the CDC continues to gather data.
Australian researchers conducted experiments on mice that they fed only every other day.
Without swift unprecedented action, more than 2 million Americans could die.
While research is underway to develop new therapies for fatty liver disease, here are steps you can take to keep your liver healthy.
Houstonian Terri Milton is determined not to let advanced fatty liver disease get the best of her.
However, having a higher body mass index might prevent this improvement.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.